Total Payments
$832.77
2021 Payments
$95.49
Companies
18
Transactions
35
Medicare Patients
848
Medicare Billing
$89,833
Payment Breakdown by Category
Food & Beverage$832.77 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $832.77 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $224.76 | 6 | $0 (2019) |
| Allergan Inc. | $136.18 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104.88 | 7 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $66.83 | 1 | $0 (2017) |
| Horizon Therapeutics plc | $39.24 | 2 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $34.00 | 1 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $33.32 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $31.84 | 2 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $31.69 | 2 | $0 (2018) |
| Gilead Sciences, Inc. | $27.73 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $95.49 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($36.41) |
| 2020 | $25.44 | 2 | Genentech USA, Inc. ($14.10) |
| 2019 | $552.40 | 20 | Amgen Inc. ($224.76) |
| 2018 | $92.61 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($31.69) |
| 2017 | $66.83 | 1 | E.R. Squibb & Sons, L.L.C. ($66.83) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/20/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: DIABETES | ||||||
| 04/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: DIABETES | ||||||
| 02/25/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: PRIMARY CARE | ||||||
| 01/28/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/21/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: PRIMARY CARE | ||||||
| 11/23/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Virology & Specialty Care | ||||||
| 09/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Diabetes | ||||||
| 12/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: DIABETES | ||||||
| 12/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: DIABETES | ||||||
| 11/23/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $42.17 | General |
| Category: Neuroscience | ||||||
| 11/23/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: Central Nervous System | ||||||
| 11/22/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $122.47 | General |
| Category: Neuroscience | ||||||
| 11/22/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $116.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Neuroscience | ||||||
| 10/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: DIABETES | ||||||
| 10/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: DIABETES | ||||||
| 06/28/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: KRYSTEXXA | ||||||
| 06/24/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Neuroscience | ||||||
| 05/02/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: KRYSTEXXA | ||||||
| 04/23/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.46 | General |
| 04/15/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: DIABETES | ||||||
| 04/08/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Neuroscience | ||||||
| 03/29/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: VACCINE | ||||||
| 03/25/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 100 | 126 | $21,681 | $8,353 |
| 2022 | 4 | 223 | 423 | $184,445 | $36,034 |
| 2021 | 12 | 356 | 550 | $219,724 | $37,684 |
| 2020 | 9 | 169 | 185 | $17,320 | $7,762 |
Total Patients
848
Total Services
1,284
Medicare Billing
$89,833
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 40 | $8,308 | $3,579 | 43.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $6,801 | $2,217 | 32.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 17 | $3,514 | $1,451 | 41.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 16 | $2,307 | $892.05 | 38.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 31 | 36 | $750.40 | $214.55 | 28.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 114 | 302 | $119,620 | $23,151 | 19.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 50 | 53 | $41,878 | $7,904 | 18.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 47 | 52 | $18,465 | $4,107 | 22.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 16 | $4,482 | $871.12 | 19.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 103 | 249 | $131,472 | $19,475 | 14.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 39 | $40,053 | $6,008 | 15.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 60 | $9,300 | $4,257 | 45.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 38 | 38 | $20,672 | $3,134 | 15.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $2,600 | $1,660 | 63.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 22 | $8,118 | $1,225 | 15.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,365 | $609.25 | 44.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 19 | 23 | $1,794 | $386.40 | 21.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 25 | 27 | $1,998 | $361.53 | 18.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 29 | 33 | $1,584 | $348.48 | 22.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 15 | 18 | $468.00 | $174.78 | 37.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 12 | 15 | $300.00 | $45.00 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 45 | $6,975 | $2,902 | 41.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 24 | $2,520 | $1,378 | 54.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $2,200 | $1,239 | 56.3% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 18 | 18 | $1,155 | $1,095 | 94.8% |
About Dr. Sarah Scott, M.D
Dr. Sarah Scott, M.D is a Family Medicine healthcare provider based in Damariscotta, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2015. The National Provider Identifier (NPI) number assigned to this provider is 1497134571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Scott, M.D has received a total of $832.77 in payments from pharmaceutical and medical device companies, with $95.49 received in 2021. These payments were reported across 35 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($832.77).
As a Medicare-enrolled provider, Scott has provided services to 848 Medicare beneficiaries, totaling 1,284 services with total Medicare billing of $89,833. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Damariscotta, ME
- Active Since 05/22/2015
- Last Updated 08/03/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497134571
Products in Payments
- Aimovig (Biological) $224.76
- BOTOX (Drug) $116.60
- ELIQUIS (Drug) $66.83
- TRADJENTA (Drug) $65.29
- JARDIANCE (Drug) $39.59
- KRYSTEXXA (Biological) $39.24
- AJOVY (Drug) $34.00
- NURTEC ODT (Drug) $33.32
- Mirena (Drug) $31.69
- BOTOX (Biological) $19.58
- BEXSERO (Biological) $16.83
- SHINGRIX (Biological) $15.01
- TRINTELLIX (Drug) $14.26
- MENACTRA (Drug) $14.21
- Xofluza (Drug) $14.10
- NASCOBAL (Drug) $14.06
- PNEUMOVAX 23 (Biological) $12.02
- FARXIGA (Drug) $11.50
- Ozempic (Drug) $11.34
- TRULICITY (Drug) $10.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Damariscotta
Dr. Allan Teel, Md, MD
Family Medicine — Payments: $768.00
Family Medicine $768.00
Cammey Young, Md, MD
Family Medicine — Payments: $56.72
Family Medicine $56.72
Dr. Minda Gold, Md, MD
Family Medicine — Payments: $52.67
Family Medicine $52.67
Jason Cienega
Family Medicine — Payments: $48.64
Family Medicine $48.64
Michael Romac, M.d, M.D
Family Medicine — Payments: $40.87
Family Medicine $40.87
Aaron Perreault, Md, MD
Family Medicine — Payments: $13.98
Family Medicine $13.98